Halozyme Therapeutics, Inc. (HALO)

NASDAQ: HALO · Real-Time Price · USD

68.32

-0.20 (-0.29%)

At close: May 22, 2026, 4:00 PM EDT

69.00

+0.68 (1.00%)

After-hours: May 22, 2026, 6:34 PM EDT

Halozyme Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	8,104	7,927	5,887	4,685	7,690	5,529
Market Cap Growth	-2.90%	34.64%	25.65%	-39.07%	39.09%	-4.70%
Enterprise Value	9,962	9,927	6,797	5,849	8,820	5,575
Last Close Price	68.32	67.30	47.81	36.96	56.90	40.21
PE Ratio	24.05	26.29	13.94	17.60	39.51	14.68
Forward PE	-	8.85	10.38	9.77	21.92	17.89
PS Ratio	5.37	5.68	5.80	5.65	11.65	12.47
PB Ratio	36.87	162.39	16.18	55.91	45.29	28.07
P/TBV Ratio	37.87	170.83	17.01	59.18	47.12	29.97
P/FCF Ratio	12.14	12.30	12.57	12.55	32.68	18.55
P/OCF Ratio	11.96	12.17	12.29	12.06	32.03	18.46
EV/Sales Ratio	6.60	7.11	6.69	7.05	13.36	12.58
EV/EBITDA Ratio	10.45	17.82	10.74	13.85	27.81	19.99
EV/EBIT Ratio	11.59	21.17	12.33	17.33	32.97	20.21
EV/FCF Ratio	14.92	15.40	14.51	15.67	37.49	18.71
Debt / Equity Ratio	8.81	43.89	4.14	17.89	8.79	4.00
Debt / EBITDA Ratio	3.50	3.85	2.38	3.55	4.75	3.14
Debt / FCF Ratio	3.21	3.32	3.22	4.02	6.40	2.94
Net Debt / Equity Ratio	8.31	40.97	2.50	13.88	6.73	0.69
Net Debt / EBITDA Ratio	2.98	3.59	1.44	2.75	3.61	0.49
Net Debt / FCF Ratio	2.74	3.10	1.94	3.12	4.86	0.46
Asset Turnover	0.58	0.61	0.53	0.46	0.45	0.53
Inventory Turnover	1.56	1.44	1.18	1.69	1.81	1.42
Quick Ratio	2.14	3.30	6.50	5.07	4.54	7.10
Current Ratio	2.76	4.66	7.80	6.64	5.65	7.91
Return on Equity (ROE)	259.89%	153.59%	198.42%	222.07%	110.23%	231.44%
Return on Assets (ROA)	13.65%	13.87%	23.16%	15.27%	14.75%	53.09%
Return on Invested Capital (ROIC)	16.11%	18.02%	33.64%	20.63%	25.58%	169.66%
Return on Capital Employed (ROCE)	21.98%	21.95%	31.11%	20.27%	19.83%	48.16%
Earnings Yield	4.30%	3.80%	7.17%	5.68%	2.53%	6.81%
FCF Yield	8.24%	8.13%	7.96%	7.97%	3.06%	5.39%
Buyback Yield / Dilution	4.58%	4.27%	3.56%	4.56%	4.22%	-3.77%
Total Shareholder Return	4.58%	4.27%	3.56%	4.56%	4.22%	-3.77%

Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q